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Abstract 
In this paper we demonstrate that aromatic oil capsules, produced by dripping droplets, can offer 
a simple, yet effective, testing tool to aid in the diagnosis of various diseases, in which the loss of 
smell is a key symptom. These include chronic neurological conditions such as Parkinson’s and 
Alzheimer’s disease, and acute respiratory infections such as that cause by Covid-19. The capsules 
were fabricated by concentrically dripping oil/alginate droplets, from a coaxial nozzle, into an 
oppositely charged ionic liquid. This fabrication technique enables full control over the capsule 
size, the shell thickness, and the volume of the encapsulated oil. After formation, liquid capsules 
were left to dry and form a solid crust surrounding the oil. The prototype test consists of placing a 
standardized number of capsules between adhesive strips that users crush and pull apart to release 
the smell. In addition to the fabrication method, a simple mathematical model was developed to 
predict the volume of encapsulated oil within the capsule in terms of the flow rate ratio and the 
nozzle size. Tensile tests show that capsule strength is inversely proportional to its size owing to 
an increase in the shell thickness. By increasing the alginate concentration, the load required to 
rupture the capsule increases, to the point where capsules are too stiff to be broken by a fingertip 
grip. Results from a preliminary screening test, within a group of patients with Parkinson’s disease, 
found that smells were detectable using a ‘forced choice’ paradigm. 
  




Although often overlooked, olfaction – the sense of smell – significantly aids our interaction with 
the environment. Its absence is associated with isolation, anhedonia [1], and depression [2]. The 
sense of taste is heavily reliant on a functioning olfactory system [3] and a reduction (hyposmia) 
or loss (anosmia) of olfaction may be a sign of a head trauma, the result of ageing or an acute or 
chronic medical disorders [4]. Loss of smell is recognized to be an early feature of 
neurodegenerative conditions, such as Alzheimer’s and Parkinson’s disease, with a prevalence of 
up to 90% in Parkinson’s disease [6]. Early detection of neurodegenerative diseases under the 
assumption that those at the earliest stages will be more likely to gain benefit from neuroprotective 
clinical trials and future treatments [7]. Separately, smell loss has emerged as an important feature 
of COVID-19 infection, with ~65% of those testing positive for COVID-19 experiencing 
subjective loss of smell or taste, compared to 22% of those testing negative [5]. People who are 
negative for COVID could still lose their sense of smell because screening tests for COVID are 
neither 100% sensitive or specific. Also there are other causes of smell loss such as head injury, 
viral infection and increasing age. 
 
The most commonly used smell tests are “scratch-and-sniff”, in that they consist of a printed slurry 
of microencapsulated beads of oil set within an adhesive material. This type of bead encapsulation 
comes from a polyoxymethylene urea matrix [8], was first produced in 1984 and is now considered 
the gold standard test to detect anosmia and hyposmia [9, 10]. The most commonly used test, the 
University of Pennsylvania Smell Identification Test (UPSIT), has 40-item “scratch-and-sniff” and 
requires users to make a forced choice for each odor based on four options [11]. While effective, 
scratch-and-sniff tests are expensive. The price of only a single test unit is around $26.95 [12], 
making it ill-suited to large screening programs likely to require thousands of tests. Furthermore, 
the amount of odour released is dependent on the extent to which the individual scratches the 
“scratch-and-sniff” strip. Based on our experience of using the 40-item UPSIT for large-scale 
testing, 10-15% of tests were either not returned or well incorrectly completed [13].  
 
Olfactory displays are an alternative method of odour delivery composed of stocked odour material 
that can be vaporised and released on demand and then smelled by the user [14]. They are an 
emerging technology in the field of virtual reality [15]. Vapours can be blended to create specific 
and complex odours and displays such as these can be adjusted and controlled to produce specific 
quantities, and therefore potencies, of odour. This is advantageous where consistent odour potency 
is required such as in a screening test. Nevertheless, olfactory displays are expensive and 
impractical to mass produce for screening and their capability to blend odours is unnecessary when 
assessing a subject’s ability to smell individual odours. Another approach of odour delivery is the 
compressed cylinders, however, these are expensive to produce and not practical; giving the 
possible dangers associated with compressed substances and the difficulty in production and 
packaging for a large screening study which requires many thousands of tests to be distributed 
easily.  
 
Here, we propose an alternative smell test consisting of capsules of a calcium alginate hydrogel 
crust surrounding a droplet of scented oil. The capsule can be ruptured manually, for the oil’s 
odour to be released. The capsules are formed by co-extrusion dripping from a coaxial double-
nozzle, enabling rapid, continuous production. Alginate is safe and frequently used to encapsulate 
a variety of products (flavors, oils, vitamins, dyes, drugs, cells) in the food, textile, cosmetic and 
pharmaceutical industries to preserving materials for long time periods [16]. This is possible due 
to the stability of the alginate matrix, formed by the simple and fast ionic gelation reaction that 
forms a nontoxic material. 
 
Past works have presented various techniques to fabricate oil-encapsulated alginate capsules with 
spherical or tubular shape, including microfluidics, jet-cutting, vibrating jet, spray-drying, 
coextrusion dripping, dispersion [16, 17]. Some of these techniques have been characterized, such 
as the coaxial-jetting used to fabricate oil-encapsulated alginate microfibers [17], but others such 
as coextrusion dripping lack such characterization hindering their capability to produce controlled 
capsules. To our knowledge, the use of oil-containing alginate capsules has never been previously 
used to test olfaction.  
  
2. MATERIAL AND METHODS 
  
2.1. Materials 
Alginic acid sodium salt from brown algae (medium viscosity) was obtained from Sigma Life 
Sciences and calcium chloride anhydrous (BioReagent) from Sigma-Aldrich. Aromatic oils 
(Cherry, Coconut, Clove, Orange (all Aromatherapy®), Menthol (MysticMoments®) and Onion 
(EcoAurous®)) were used as capsule core materials. Alginate (polymer) solutions were prepared 
at 2.0 and 4.0 wt% concentrations by dissolving the polymer in tri-distilled water. The polymer 
was let to dissolve for at least 8 hours to achieve homogenous solutions. All calcium chloride 
aqueous solutions were prepared at a 1.0 M concentration. Aromatic oils were used undiluted and 
all solutions were stored at room temperature (25 C) in PTFE bottles prior used and then transferred 
into plastic 5.0 ml syringes. A cone/plate viscometer (Brookfield DV-1) was used to measure the 
viscosity of the alginate solutions and the oil, while a pendent drop technique was adopted to 
measure the liquid surface tension and the liquid-liquid interfacial tension (Table 1). 
 
Table 1 Properties of the liquids used in the experiments 
Liquid ρ (kg·m-3) (mN·m-1) µ (mPa·s) 
Alginate 2%/ air 1050 68.5 150 
Alginate 4%/ air 1080 46.8 990 
Cherry oil/ air 918 20.25 34.8 
Cherry oil/Alginate 2% ------- 46.4 ------ 














2.2. Experimental method 
  
 
Figure 1. a) The experimental set up for the encapsulation process, b) the crosslinked capsule under the 
microscope showing the alginate shell and the encapsulated oil in the core, and c) the smell test delivery 
package. 
 
Capsules were fabricated using a coaxial drop dripping system. The apparatus consists of a coaxial 
nozzle manufactured in-house (Figure 1a) where the inner needle was made from stainless steel 
with a diameter 𝑑𝑛𝑖 = 0.9 mm and a glass needle with outer diameter 𝑑𝑛0 = 3.0 mm. This 
arrangement facilitated the visualization of the coaxial drop formation. The tips of the inner and 
the outer needles were vertically set at the same height. Capsule formation was visualized by a 
high-speed camera (Chronos 1.4) and a lamp (Schott KL 1500) directed onto an optical diffuser to 
provide a uniform background. This camera was used to identify the conditions for successful 
encapsulation. Two syringe pumps (Harvard Apparatus PHD 2000 HPSI), running simultaneously, 
fed the coaxial nozzle with the capsule materials. The first syringe pump infused alginate solution 
from a 50 ml syringe, through plastic tubing, into the outer nozzle. The second syringe pump 
infused scented oil from a 5.0 ml syringe, via plastic tubing, into the inner needle. The continuous 
injection of both immiscible liquids led to the formation, and subsequently breakup, of a coaxial 
drop in which the scent oil was encapsulated inside the alginate solution. The double-nozzle was 
held vertically at a height of 25.0 mm above the surface of the 1.0 M CaCl2 solution bath (measured 
from the nozzle tip). The ionic gelation of alginate was triggered once the droplet touched the 
calcium solution during the dripping process into the solution bath, where divalent cations form 
a crosslinked shell of alginate with the scent oil contained inside (Figure 1b).  
 
After 10 min gelation, capsules were removed from the calcium chloride solution using a spatula, 
and then left to dry for 24 hours on paper filter under ambient conditions (24 ℃). Then, the 
capsules were placed in a transparent petri dish for characterization. The size and thickness of the 
capsules were recorded by optical microscopy (using a Olympus SZX16 microscope) before and 
after drying. Finally, tensile tests were carried out on the dry capsules using a compression-testing 
machine (Instron 3342, 5 and 50 N load cell) to examine the load required to break the capsules. 
 
3 RESULTS AND DISSCUSION 
 
3.1 Encapsulation process  
Figure 2. Size of measured (a) wet capsules diameter 𝑑𝑤 , and (b) dry capsules diameter  𝑑𝑑 for different 
flow rates. Closed symbol refers to 2% alginate capsules, while open symbol is for 4% alginate capsules at. 
 
Coaxial drops (oil drop inside alginate drop) were formed at the tip of the coaxial nozzle as a result 
of the continuous injection of alginate and oil liquids at constant flowrates 𝑄𝑎𝑙 and 𝑄𝑜𝑖𝑙. A coaxial 
drop detached from the nozzle when its body weight was greater than the capillary force holding 
it at the rim of the nozzle. This results in a drop with a diameter that follows the scaling 𝑑𝑤  𝑑𝑛0⁄ =
2𝛼𝐵−𝛽, where 𝐵 = |𝜌𝑖 − 𝜌𝑜|𝑔𝑑𝑛𝑜
2 4𝜎⁄  is Bond number, 𝜌𝑖 and 𝜌𝑜 are the drop and the 
surrounding medium densities, 𝜎 is the outer liquid surface tension, and 𝛼 and 𝛽 are fitting 
parameters with values 4.46 and 0.356 respectively [18]. According to this approximation, the 
liquids flow rate does not have an effect on the detached drop size, but only to the frequency of 
drop production. Figure 2a shows the detached coaxial drop size in terms of the alginate and oil 
flow rates demonstrating this argument. As seen, the drop average size for 4% alginate solution 
(dashed line) is slightly lower than that of the 2% alginate (solid line) given differences in surface 
tension of the alginate solutions, Table 1.  
 
After the alginate coaxial drop is cross-linked by the calcium chloride and are left to dry, the shell 
thickness shrinks giving a different dry capsule size. The final capsule size depends on the oil to 
alginate flow rate ratio through the relation 𝑑𝑑 𝑑𝑛𝑜⁄ = 𝐶(𝑄𝑜𝑖𝑙/ 𝑄𝑎𝑙)
𝑘 (Figure 2b) as evaporation 
in the alginate shell increases with its thickness. 𝐶 and 𝑘 are fitting parameters that reflect the 
contraction of the alginate bead during drying with values 0.2 and 1.2 respectively.   
 
Figure 3. Capsules size distribution. 
 
Total of 180 measurement were taken to show the dry capsule size histograms corresponding to 
two different flow rates fractions, 𝑄𝑜𝑖𝑙/𝑄𝑎𝑙 = 0.2 and 0.4 (Figure 3). In addition, it can be seen 
that a higher flow rate ratio results in a more uniform size distribution (i.e. the relative standard 
deviations were found to be 4.7% and 2.7%, respectively). This reflects the high uniformity of the 
produced capsules. 
Experiments were conducted with different alginate and oil flow rates to identify the conditions 
for optimum encapsulation. The range of flow rates studied were 𝑄𝑎𝑙 = 0.2 to 16 ml/hr  
and 𝑄𝑜𝑖𝑙 = 0.1 2 to 8 ml/hr. Figure 4a shows the encapsulation parameters for a 2% alginate 
solution. As observed, single oil drops are successfully encapsulated inside alginate (circle 
symbols) for conditions where 𝑄𝑜𝑖𝑙/𝑄𝑎𝑙 < 0.5. For higher flow rate ratios, the volume of alginate 
supplied is not enough to cover the oil drop and the oil escapes and fails to produce the capsule 
(rectangular symbols). The same flow rate limit was observed for 4% alginate solutions (Figure 
4b). However, unlike the encapsulation experiments with 2% alginate, another behavior was found 
where more than one oil drop could be encapsulated inside the alginate (triangle symbols). This 
was found to occur at 𝑄𝑜𝑖𝑙 > 0.5 ml/hr and is explained by the differences in the interfacial 
tension between oil and the 4% and 2% alginate, Table 1. This difference permits the detachment 
of smaller oil drops from the inner nozzle and hence more than one oil drop can drip within the 
outer drop.   
Figure 4. Encapsulation map for a) 2% alginate capsules and b) 4% alginate capsules. 
 
The volume of aromatic oil that can be encapsulated, for a coaxial drop formation, is readily 
obtained from the flowrate of the inner needle  𝑄𝑖 = 𝑉𝑑𝑖 𝑡𝑏⁄ , where 𝑉𝑑𝑖 is the volume of the inner 
drop and 𝑡𝑏 is the breakup time of the coaxial drop. On the other hand, the outer needle flow rate 
is given by 𝑄𝑜 = 𝑉𝑑𝑜 𝑡𝑏⁄ , where 𝑉𝑑𝑜 = 𝑉𝑇 − 𝑉𝑑𝑖, and 𝑉𝑇 is the total volume of the coaxial drop just 
before the breakup. Assuming that 𝑉𝑇~𝑑𝑛𝑜
3, the outer needle flow rate is then given by 𝑄𝑜 ≅
(𝑑𝑛𝑜
3 − 𝑉𝑑𝑖) 𝑡𝑏⁄ .  
From this analysis a simple relation of the encapsulated drop volume is obtained as 
     𝑉𝑑𝑖 𝑑𝑛𝑜
3⁄ ≅  𝑄𝑖/ 𝑄𝑇,                                                                 (1)  
where 𝑄𝑇 =  𝑄𝑖 +  𝑄𝑜. Our experimental data shows an excellent agreement with this relationship 
(see Figure 5). 
 
 
Figure 5. Dimensionless encapsulated volume 𝑉𝑑𝑖 𝑑𝑛𝑜
3⁄  as a function of the flow rate ration 𝑄𝑖/𝑄𝑇. 
 
3.2 Capsule material characterisation 
 
The capsule strength in terms of wall thickness was characterised to identify conditions where they 
could be ruptured by a fingertip grip to release the odour. Capsules of 2.0% and 4.0% alginate 
concentrations were tested and the maximum load required to break them was measured using the 
compression to failure test. As expected, larger deformations were required to break larger 
capsules (Figure 6a), and decreasing the capsule size increased the rupture load. The rupture load 
as a function of the thickness is found in Figure 6b. Small capsules were found to have a thicker 
shell and required an increased load to rupture. Additionally, our results indicate that the rupture 
load dramatically increases with alginate concentration as this results in an excess of polymer 
chains becoming crosslinked within the gel making the shell stiffer. These results are consistent 
with the behavior observed elsewhere, on the production of oil-core Ca-alginate capsules [19]. 
Importantly, our test shows that the load required to break all the 2.0% alginate capsules (25 to 45 
μm thickness) is below the 6.0 N fingertip critical grip [20] making them ideal for patient use. At 
4.0% alginate concentrations, capsule thicknesses higher than 33 μm were found to break above 
the critical fingertip grip limit, making these capsules inappropriate for patient use.  
Figure 6. Mechanical strength of various capsules. a) Deformation of capsules versus the applied load. b) 
Shell thickness versus the load required to rupture the capsule. 
 
3.3 Smell test performance 
 
Capsules were placed between two strips of single-sided tape where the capsules are crushed 
between fingers or between the thumb and a solid surface. The tape strips are then peeled apart 
and the odour is released and can be detected. Sketch of the capsule delivery method is illustrated 
in Figure 1c and photos of the unit are shown in Figure 7. The unit has dimensions of 7 cm long 
and 2 cm width. In our tests, 48 of these delivery devices were manufactured, number-coded 
(associated with a number) and stored in separate plastic bags before testing with patients.  
 
Figure 7. Photos of the proposed capsule delivery unit. 
 
A small group of eight patients with Parkinson’s disease were recruited to perform two smell 
battery runs; one “scratch-and-sniff” test (SSA) containing six odours (coconut, menthol, cherry, 
orange, clove and onion) and the other consisting of the same six odours but using the alginate-
encapsulated sniff test (EST). A random number generator determined which test battery would 
be performed first. The scratch-and-sniff was delivered in the form of a booklet where patients 
were asked to scratch individual sections to then identify the odour released from a list of four 
options (one correct option and three distractor options). Odours were different for each run and, 
once completed. The EST battery consisted of the same six odours and patients had a list of four 
options – consistent with the scratch-and-sniff test. Each time, after scratching or rupturing an 
item, the patient was asked to immediately smell and either communicate or circle an answer. 
There was no time limit, though both types of test usually took around 5 minutes to complete. 
Patients were given a score out of six for both tests and asked which testing method they preferred 
to perform of the two, including the reasons for their choice. During the test, all EST capsules (n 
= 48) were ruptured successfully, releasing the odour. No issues were reported on the manipulation 



















Figure 8. Comparison between the performances of our encapsulated smell test (EST) and the scratch and 
smell test (SSA). 
 
Figure 8 compares the percentage of participants correctly identifying a particular odour for each 
test. For both tests, onion and clove odours were some of the easiest to identify. As seen, odours 
were easier to identify in the EST exercise (oil volumes of 5.0 mm3 was encapsulated and released 
while breaking). When asked, five out of the eight participants said they preferred the encapsulated 
smell delivery method to the scratch-and-sniff method (primarily citing the relative ease process 




In this study, we present a method that uses drops dripping from a coaxial nozzle to fabricate a 
cheap and fast smell test. The test consists of rupturing alginate capsules containing a scented oil 
to then identify the released odour. Unlike the traditional “scratch and sniff” testing, the amount 
of released odor can be controlled more effectively by the encapsulated volume in the proposed 
single capsule-based approach. The encapsulation process of aromatic oils into alginate was 
characterized and a parametric map for conditions for the successful encapsulation was 
established. The proposed method is consistent and produces homogeneous capsules in both size 
and volume of scented oil. Capsules are stable for long time periods at room temperature and, in a 
small proof-of-concept study, the capsules effectively and consistently release odour when 
ruptured by participants showing a better performance in comparison with the traditional scratch 
and sniff test.  
 
Our findings indicate that aromatic oil is successfully encapsulated for flow rate ratios 𝑄𝑜𝑖𝑙/𝑄𝑎𝑙 <
0.5. For low oil/alginate interfacial tensions (33 mN/m), and 𝑄𝑜𝑖𝑙 > 0.5 ml/hr, we found 





, was derived and experimentally verified to determine the volume of oil encapsulated. 
This relationship indicates that the amount of encapsulated oil is independent on the properties of 
the injected liquids and is only a function of the flow rate ratio and the external nozzle size. The 
mechanical testing of the capsules indicate that 2.0 % alginate capsules are appropriate for patient 
use as they can be easily ruptured by a fingertip grip, particularly for elderly people who might 
have developed neurological conditions such as Alzheimer's and Parkinson's diseases. The 
proposed device may be used also to diagnose COVID-19. Current estimates suggest over 65% of 
those who have had COVID-19 had a reduced smell sense [5] and assessing smell and taste may 
predict a positive COVID-19 antigen test better than assessing fever or dry cough.  
 
Our novel encapsulated test advantage over the scratch-and-sniff delivery method is that oil 
quantity, and therefore odour potency, can be precisely controlled so that an optimum potency, at 
which sensitivity and specificity of the test is highest, can be established. However, more research 
is required to quantify this value and it may vary depending on whether a test is screening for 
COVID-19, neurological conditions or another cause of hyposmia, as the extent of olfactory 
dysfunction may differ with each condition. 
 
 
Ethics. Patients were tested as part of the East London Parkinson's Disease Project (research ethics 
reference number 18/SW/0255). Patients were recruited from the Parkinson’s Disease Clinic at 
The Royal London Hospital over 3 separate clinic days. After their clinic consultation, patients 
were asked whether they would like to partake in a study assessing sense of smell. Those that 
agreed completed both a scratch-and-sniff smell test and the novel oil encapsulated smell test. 
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